FibroGen (NASDAQ:FGEN) Coverage Initiated at StockNews.com
StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report released on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on FGEN. William Blair reissued a “market perform” rating on shares of FibroGen in a research note […]
StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report released on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on FGEN. William Blair reissued a “market perform” rating on shares of FibroGen in a research note […]
